Liver Transplantation

Article	Citations
CON: It’s time for new strategies to optimize liver transplant immunosuppression	91
No RETREAT: Moving forward in post-transplant HCC recurrence prediction	52
Tobacco use, cirrhosis, and age are predictors of readiness to change and continued drinking following brief alcohol intervention in veterans	51
Indocyanine green fluorescence quantification during normothermic ex situ perfusion for the assessment of porcine liver grafts after circulatory death	48
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation	45
Donor eligibility criteria and liver graft acceptance criteria during normothermic regional perfusion	43
Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis	41
High time for common ground in the assessment of steatosis	38
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	38
Novel approaches are needed to study social determinants of health in liver transplantation	37
What Survivorship Means to Liver Transplant Recipients: Qualitative Groundwork for a Survivorship Conceptual Model	37
Measurements matter: Assessing outcomes in “lean” patients with nonalcoholic fatty liver disease awaiting liver transplantation	34
Long-term instead of repetitive treatment: benefits of primary stenting for portal vein stenosis in pediatric liver transplantation	33
The Organ Procurement and Transplantation Network hepatocellular carcinoma classification: Alignment with Liver Imaging Reporting and Data System, current gaps, and future direction	32
Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy	32
Alpha‐fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha‐fetoprotein at liver transplantation	32
Active coping, resilience, post-traumatic growth, and psychiatric symptoms among early and late liver transplant survivors	31
Portopulmonary hypertension practice patterns after liver transplantation	31
Postoperative fibrinolytic resistance is associated with early allograft dysfunction in liver transplantation: A prospective observational study	30
Letter to the Editor: Aberrant arteries—1 may be better than 2 for the liver, but maybe not the bile duct	30
Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations	29
CAQ Corner: Disease recurrence after liver transplantation	29
An extensive evaluation of hepatic markers of damage and regeneration in controlled and uncontrolled donation after circulatory death	29
	28
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time	28

Semaglutide is effective in achieving weight loss in liver transplant recipients	26
Inequity in access to liver transplant care: Time to make the invisible visible	25
Utilization of biomarkers for alcohol use in candidates for liver transplantation with alcohol-associated liver disease	25
Clinical outcomes in patients with unintended pregnancy after liver transplantation: A multicenter registry cohort study	25
Incremental impact of organ allocation changes and machine perfusion technology on liver transplant waitlist and volumes	25
Cystatin C in decompensated cirrhosis: Shedding the excess baggage in clinical practice	24
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: Prevalence, noninvasive diagnosis, and burden on surgical outcomes	24
Role of mentorship in the learning curve of robotic right lobe donor hepatectomy	24
Performance of race-neutral eGFR equations in patients with decompensated cirrhosis	24
Letter to the Editor: Time for validating GEMA-Na in the United States for liver transplant waiting list prioritization	24
Early living donor liver transplantation for alcohol-associated hepatitis: Status in the era of increasing demand, unmet needs, and future considerations	23
Combining radiomics and imaging biomarkers with clinical variables for the prediction of HCC recurrence after liver transplantation	23
Racial and ethnic disparities in extended criteria allograft use for liver transplantation	23
Recompensation of cirrhosis in candidates of transplant: Tips and tricks for delisting	22
Development of posttransplant diabetes mellitus in US recipients of liver transplant is influenced by OPTN region	22
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in 3 different European countries	22
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey	21
Acute liver failure: Do we have a consensus regarding management?	21
Letter to the Editor: Survey of attitudes and knowledge of early paracentesis guidelines and performance in providers in the Veterans Health Administration	21
Erratum: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US multicenter HCC	21
Low frequency of HBsAg reemergence in liver transplant recipients after stopping hepatitis B immune globulin: Implications for prophylaxis protocols	21
Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation	21
Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol	21
Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design	21
Letter to the Editor: Technical advances in living donor liver transplantation: Maintaining a view of both donor and recipient outcomes	20
“Winning the peace” against obesity in recipients of liver transplant	20
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients	20
Breathing new life to posttransplant survival models	20
Sarcopenic obesity may predict worse liver regeneration after right graft living donor liver transplantation	20
Issue Information ‐ Author Checklist	20
2024 Reviewers (Volume 30)	20
Quantitative methods for optimizing patient outcomes in liver transplantation	20
Anonymous Nondirected Living Liver Donation: Has the Time Come to Formalize the Process?	20
Issue Information ‐ Instructions to Authors	20
An international, multicenter, survey-based analysis of practice and management of acute liver failure	20
Issue Information	19
Issue Information	19
Beware of Portal Vein Thrombosis After Laparoscopic Sleeve Gastrectomy in Liver Transplant Recipients	19
Exploring the lower weight limit of splitable liver grafts for pediatric recipients	18
Donor-derived disorders of hemostasis and thrombosis in liver transplantation: Considerations for deceased donor liver selection	18
Letter to the Editor: Long-term experience in treating autoimmune hepatitis with acute presentation	18
Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants	18
Family planning and donor type: Unrecognized benefits of living donor liver transplantation?	18
Hypothermic oxygenated machine perfusion as a tool to facilitate liver transplantation in the acute‐on‐chronic liver failure scenario	18
Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?	18
Letter to the Editor: Can sexagenarian donors be feasibly indicated for living donor liver transplantation?	18
Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?	17
Distal Gastroduodenal Arterial Inflow as a Salvage Strategy for Extensive Intraoperative Arterial Dissection in Living Donor Liver Transplantation	17
Protein induced by vitamin-K absence II: Another key to create a common language	17
Issue Information	17

ILTS Annual Congress 2024 Abstracts	17
Empowering liver transplantation: The role of minimally invasive hepatectomy in advancing living donation	17
Reply: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	16
Unseen foe: The financial toxicity of liver transplantation	16
Issue Information ‐ Instructions to Authors	16
Gastrointestinal Infection and Liver Injury Are the Risk Factors for Coronavirus Disease 2019 Inpatients With Assisted Ventilation	16
Deceased donor selection and management	16
Issue Information ‐ Instructions to Authors	16
Prediction of long‐term morbidity and mortality after liver transplantation using two‐dimensional shear wave elastography compared with liver biopsy	16
Pregnancy Outcomes After Living Liver Donation: A Multi‐Institutional Study	16
Pediatric liver transplant recipients are not just young adults: The importance of a structured health care transition program in adult transplant centers	15
Liver transplant evaluation redux: Hope for reconsidering previously declined candidates with alcohol-associated liver disease	15
Occult Hepatocellular Carcinoma Associated With Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients	15
Reply: Blocked drain switch—hepatic venous outflow obstruction	15
Does liraglutide alleviate inflammation in brain-dead donors? A randomized clinical trial	15
Reply: The urgent need for consensus around organ donation after assisted dying	15
Utility of Preoperative Computed Tomography–Based Body Metrics in Relation to Postoperative Complications in Pediatric Liver Transplantation Recipients	15
Affordable Care Act Medicaid expansion associated with increased liver transplant waitlist access without worsening mortality	15
Letter to the Editor: Posthepatic-ischemia-reperfusion injury–related AKI: A need for better biomarkers and interventions to mitigate the risk	15
Sleep disturbances in chronic liver disease	14
Letter to the Editor: The urgent need for consensus around organ donation after assisted dying	14
Outcomes of Kidney Allograft and Recipient Survival After Liver Transplantation by Induction Type in the United States	14
Equivalence of the adapted electronic Pediatric Liver Transplant Quality of Life (PeLTQL) questionnaire: A patient-reported outcome measure for children and teens	14
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population	14
Comparison of pure laparoscopic donor right posterior sectionectomy versus right hemihepatectomy for living donor liver transplantation	14
Operationalizing multidisciplinary liver tumor boards for hepatocellular carcinoma	14
Unlocking metabolic flexibility: Is this the key to preventing weight gain in liver transplant recipients?	14
Chronic Kidney Disease After Simultaneous Liver‐Kidney Transplantation: Refining Patient Selection	14
The Evaluation of Cirrhotic Cardiomyopathy in Liver Transplantation Candidates: An Emerging Debate	14
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	14
The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death	13
Sixty years of functional clotting assays in pediatric liver transplantation	13
Outcome of living donor liver transplantation for patients older than 70 years, with respect to preserved performance status and graft quality	13
Proceedings of the 28th Annual Congress of the International Liver Transplantation Society	13
Reply	13
Issue Information ‐ Author Checklist	13
PRO: How satellite clinics can improve access to liver transplantation	13
Intraoperative indocyanine green fluorescence imaging to predict early hepatic arterial complications after liver transplantation	13
CAQ Corner: The practical assessment and management of sarcopenia, frailty, and malnutrition in patients with cirrhosis	13
Reply: Stapled cavo-cavostomy in liver transplantation—Well-known tools in a new technique	13
Impact of acuity circles on racial and ethnic disparities in liver transplantation	13
The BIG question: Can we stop the use of HBIG?	13
Issue Information	12
Left Lobe Living Donor Graft Could Be a Good Choice for Liver Transplantation	12
Reconstruction of all hepatic arteries in right lobe grafts with 2 hepatic arteries and zero percent hepatic artery thrombosis	12
Preoperative assessment of body composition and sarcopenia in candidates for multivisceral transplant ​​​​​​	12
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic	12
Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation	12
Making the best use of testing for blood phosphatidylethanol	12
Issue Information	12
Liver Transplantation in Short Telomere‐Mediated Hepatopulmonary Syndrome Following Bone Marrow Transplantation Using HCV Positive Allografts: A Case Series	12
Current Quandaries in the Management of Congenital Portosystemic Shunts	12
Intranodal Sirolimus Induces Regulatory T Cells in Human Hepatic Lymph Nodes via Interleukin 10 Signaling	12
Viscoelastic Monitoring in Liver Transplantation	11
Combination of Donor Anthropometrics With Recipient Imaging to Improve Matching in Liver Transplantation	11
Improved outcomes of ABO-incompatible living donor liver transplant with biologically related donors	11
Outcomes of liver transplantation in recipients with previous coronavirus disease 2019 infection	11
Liver Transplantation From Controlled Donation After Circulatory Death Donors With Normothermic Regional Perfusion Versus Donation After Brain Death Donors	11
Seeking Editor for Clinical Liver Disease	11
Anonymity: What does it mean and why is it important to anonymous living liver donors?	11
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation	11
Reply	11
Issue Information	11
Burnout Among Transplant Hepatologists in the United States	11
Reply	11
PRO: Patients with acute-on-chronic liver failure should receive MELD exception points	11
Introducing the History, Culture, and Liver Disease series	10
Issue Information ‐ Instructions to Authors	10
Domino liver transplantation: Expanding the liver donor pool to the pediatric recipient	10
Issue Information	10
Erratum	10
Issue Information	10
Issue Information	10
Issue Information	10
Promising role of two‐dimensional shear wave elastography in the prediction of long‐term morbidity and mortality after liver transplantation	10
Financial burden in adults with chronic liver disease: A scoping review	10
Incidence and risk factors for chronic rejection in pediatric liver transplantation	10
Long‐term Outcomes of Stent Placement Inside the Bile Duct for Biliary Strictures After Living Donor Liver Transplantation	10
Issue Information ‐ Instructions to Authors	10
Issue Information	10

Erratum	10
Telemedicine in Hepatology: Current Applications and Future Directions	9
Issue Information ‐ Instructions to Authors	9
Distal Gastroduodenal Arterial Inflow as a Salvage Strategy for Extensive Intraoperative Arterial Dissectıon in Living Donor Liver Transplantation	9
Impact of the Kasai Procedure and the Length of Native Liver Survival Time on Outcomes of Liver Transplantation for Biliary Atresia	9
Adverse effects of graft congestion and ameliorative effects of hepatocyte growth factor after liver transplantation in rats	9
Introducing the Certificate of Added Qualification (CAQ) Corner	9
Issue Information ‐ Instructions to Authors	9
Transjugular intrahepatic portosystemic shunt for the patients on the liver transplant list	9
Deep learning and the future of the Model for End‐Stage Liver Disease–sodium score	9
Circulating Tumor Cell–Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue‐Based Messenger RNA Profiling Into a Noninvasive Setting	9
Implications and Management of Cirrhosis‐Associated Immune Dysfunction Before and After Liver Transplantation	8
Portal vein complications and outcomes following pediatric liver transplantation: Data from the Society of Pediatric Liver Transplantation	8
Three Problems, Two Viruses, and One Man with a Vision and Voice: Larry Kramer, Medical Activist	8
Issue Information	8
Early Survivorship After Liver Transplantation: A Qualitative Study Identifying Challenges in Recovery From the Patient and Caregiver Perspective	8
Maximizing outcomes by donor-recipient age matching in liver transplantation	8
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	8
The Impact of Primary Liver Disease and Social Determinants in a Mixed Donor Liver Transplant Program: A Single‐Center Analysis	8
Prolonged time from cross-clamp until normothermic machine perfusion start is associated with an increased risk of early allograft dysfunction following DCD liver transplant	8
The Toronto Postliver Transplantation Hepatocellular Carcinoma Recurrence Calculator: A Machine Learning Approach	8
CON: All patients should not receive a palliative care consult during LT evaluation	8
Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study	8
Disparities in travel time to liver transplantation centers in the United States	8
Best Practices in Large Database Clinical Epidemiology Research in Hepatology: Barriers and Opportunities	8
Risk Factors for Posttransplantation Mortality in Recipients With Grade 3 Acute‐on‐Chronic Liver Failure: Analysis of a North American Consortium	8
Split liver transplantation and allocation policy: an uncertain connection	8
Neoadjuvant programmed cell death 1 inhibitor before liver transplantation for HCC is not associated with increased graft loss	8
Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients	8
The Prognostic Utility of Intraoperative Allograft Vascular Inflow Measurements in Donation After Circulatory Death Liver Transplantation	8
Immunosuppression protocols for emerging oncological indications in liver transplantation: A systematic review and pooled analysis	8
Cutting deep: Understanding the risks associated with postoperative infections in patients with cirrhosis	7
Trends in surgical volume and mortality by surgery type among patients with cirrhosis: A Veterans Affairs study	7
Interprofessional teams are crucial to reduce transplantation hepatology burnout	7
CAQ Corner: Pediatric indications for liver transplantation	7
CON: Patients with acute-on-chronic liver failure should not be offered MELD exception points	7
Reappraisal of tacrolimus levels after liver transplant for HCC: A multicenter study toward personalized immunosuppression regimen	7
The landscape of liver transplantation for patients with alcohol-associated liver disease in the United States	7
	7
Acute kidney injury after adult liver transplantation—Doesn’t intraoperative management matter?	7
Cannabinoids in Colorado: Liver Transplantation Recipients Follow National Trends	7
Transplantation’s next frontier: The promise of deceased donor studies	7
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety	7
Issue Information	7
Principles for simulating the organ allocation system	7
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?	7
	7
Issue Information ‐ Author Checklist	7
A standardized immunosuppressive regimen for patients who received liver transplantations treated with atezolizumab–bevacizumab to avoid graft rejection?	7
Feasibility of steroid-free tacrolimus-basiliximab immunosuppression in pediatric liver transplantation and predictors for steroid requirement	7
Positron emission tomography myocardial perfusion imaging (PET MPI) findings predictive of post-liver transplant major adverse cardiac events	7
Those Donor Leucocytes Again? This Time It’s VITT!	7
Issue Information	7
Weight to go!—Glucagon-like peptide 1 receptor agonists in liver transplant recipients	7
A holistic approach is needed for the treatment of alcohol use disorder	7
Intensive locoregional therapy before liver transplantation for colorectal cancer liver metastasis: A novel pretransplant protocol	7
A snapshot of challenges and opportunities faced by the scientific workforce in liver transplantation — a survey of the International Liver Transplantation Society (ILTS)	7
The impact of recipient hypernatremia on pediatric liver transplantation outcomes	7
Role of protein induced by vitamin-K absence-II in transplanted patients with HCC not producing alpha-fetoprotein	7
Hepatic steatosis after liver transplantation: a systematic review and meta-analysis	7
Reply	7
Gut Microbial Signature of Hepatocellular Cancer in Men With Cirrhosis	6
Challenging the Traditional Paradigm of Supply and Demand in Pediatric Liver Transplantation Through Nondirected Living Donation: A Case Series	6
Seeking Editor for Hepatology Communications	6
Long‐term follow‐up of living liver donors	6
Implementation of a National Liver Review Board for exception requests in the United States: A 2-year monitoring report	6
Renal dysfunction after liver transplantation for polycystic liver disease	6
Reexamining “psychosocial clearance”: A procedural framework for psychosocial evaluation in liver transplantation	6
Operational tolerance is not always permanent	6
Prospective evaluation of cystatin C in the assessment of kidney dysfunction and survival in liver transplant candidates	6
Reply	6
Issue Information ‐ Instructions to Authors	6
Issue Information ‐ Author Checklist	6
Liver Transplantation in Portopulmonary Hypertension: Another Piece of the Puzzle?	6
Living Donor Liver Transplantation: Is Recipient Age a Barrier?	6
Issue Information	6
Sex and racial disparities in living donor liver transplantation in the United States	6
Remembrance of a Passing Pandemic	6
Access and outcomes in liver transplant candidates: How and when we measure is as important as what we measure	6
Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study	6
Letter to the Editor: Redo hepatic artery reconstruction for thrombosis without retransplantation in 1355 adult living donor liver transplantations	6
Policy Corner: HCC exception update	6
Issue Information	6
Performance of risk prediction models for post-liver transplant patient and graft survival over time	6
Issue Information ‐ Instructions to Authors	6
Liver transplantation for refractory hepatic hydrothorax is associated with a greater survival benefit compared to other complications of cirrhosis	5
No Foul Play for Transjugular Intrahepatic Portosystemic Shunts in Liver Transplantation for Hepatocellular Carcinoma	5
Estimating Glomerular Filtration Rate in Cirrhosis: A Variable Science That Needs Clinical Awareness	5
Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy	5
Letter to the Editor: Can semaglutide result in a tangible cardiovascular benefit in recipients of liver transplants?	5
Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study: Erratum	5
Splenic Artery Transposition for Hepatic Artery Reconstruction During Liver Transplantation: Is It the Best Choice for Adequate Arterial Inflow in Extraordinary Conditions?	5
Reduction of Visceral Adiposity as a Predictor for Resolution of Nonalcoholic Fatty Liver in Potential Living Liver Donors	5
Extracorporeal membrane oxygenation for cardiopulmonary failure in organ donation: Assessing liver transplant outcomes	5
Reply	5